MX348303B - Métodos y composiciones para la evaluación de lesión renal utilizando ácido hialurónico. - Google Patents

Métodos y composiciones para la evaluación de lesión renal utilizando ácido hialurónico.

Info

Publication number
MX348303B
MX348303B MX2013003204A MX2013003204A MX348303B MX 348303 B MX348303 B MX 348303B MX 2013003204 A MX2013003204 A MX 2013003204A MX 2013003204 A MX2013003204 A MX 2013003204A MX 348303 B MX348303 B MX 348303B
Authority
MX
Mexico
Prior art keywords
compositions
methods
hyaluronic acid
evaluation
renal injury
Prior art date
Application number
MX2013003204A
Other languages
English (en)
Other versions
MX2013003204A (es
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
James Patrick Kampf
John A Kellum Jr
Singbartl Kai
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of MX2013003204A publication Critical patent/MX2013003204A/es
Publication of MX348303B publication Critical patent/MX348303B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invención se refiere a métodos y composiciones para hacer un monitoreo, diagnóstico, pronóstico y determinación de regímenes de tratamiento en sujetos que sufren o se sospecha que tienen una lesión renal. En particular, la invención se relaciona con el uso de pruebas que detectan uno o más del ácido hialurónico (AH) como pruebas de biomarcadores de diagnóstico y pronóstico en lesiones renales.
MX2013003204A 2010-09-24 2011-09-23 Métodos y composiciones para la evaluación de lesión renal utilizando ácido hialurónico. MX348303B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38642110P 2010-09-24 2010-09-24
PCT/US2011/053015 WO2012040592A1 (en) 2010-09-24 2011-09-23 Methods and compositions for the evaluation of renal injury using hyaluronic acid

Publications (2)

Publication Number Publication Date
MX2013003204A MX2013003204A (es) 2013-06-05
MX348303B true MX348303B (es) 2017-06-06

Family

ID=45874188

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013003204A MX348303B (es) 2010-09-24 2011-09-23 Métodos y composiciones para la evaluación de lesión renal utilizando ácido hialurónico.

Country Status (13)

Country Link
US (1) US20130252264A1 (es)
EP (1) EP2619231B1 (es)
JP (1) JP2013541005A (es)
KR (1) KR20140051099A (es)
CN (2) CN106248921A (es)
AU (1) AU2011305197B2 (es)
BR (1) BR112013006631A2 (es)
CA (1) CA2813011A1 (es)
EA (1) EA201390294A1 (es)
ES (1) ES2619617T3 (es)
MX (1) MX348303B (es)
NZ (1) NZ609126A (es)
WO (1) WO2012040592A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2882767B1 (en) * 2012-08-11 2023-07-12 Astute Medical, Inc. Evaluating renal injury using hyaluronic acid

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
JPH05504841A (ja) 1990-09-14 1993-07-22 バイオサイト・ダイアグノスティックス・インコーポレイテッド リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
WO1992018866A1 (en) 1991-04-10 1992-10-29 Biosite Diagnostics Incorporated Novel conjugates and assays for simultaneous detection of multiple ligands
DE69228682T2 (de) 1991-04-10 1999-07-01 Biosite Diagnostics Inc., San Diego, Calif. "crosstalk"- oder übersprech-inhibitoren und ihre verwendung
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
JP2004208693A (ja) * 2002-12-17 2004-07-29 Sanyo Chem Ind Ltd 抗ヒアルロン酸抗体、これを含む試薬キット、抗ヒアルロン酸抗体の製造法及びヒアルロン酸の測定法
US20070259380A1 (en) * 2004-05-20 2007-11-08 Kyoichi Sumida Method for Measuring Hyaluronic Acid Using Hyaluronic Acid Binding Protein
CN102065904A (zh) * 2008-04-18 2011-05-18 药物影像股份有限公司 肾功能分析方法和装置
US20090298106A1 (en) * 2008-05-30 2009-12-03 Therapeutic Monitoring Services, L.L.C. Methods for Monitoring Immunosuppressant Drug Levels, Renal Function, and Hepatic Function Using Small Volume Samples
WO2010022210A2 (en) * 2008-08-21 2010-02-25 Pxbiosciences Llc Diagnosis and monitoring of renal failure using peptide biomarkers
AU2009285550B2 (en) * 2008-08-28 2015-06-18 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US8501489B2 (en) * 2008-09-26 2013-08-06 University of Pittsburgh—of the Commonwealth System of Higher Education Urinary biomarkers to predict long-term dialysis
MX2011008323A (es) * 2009-02-06 2011-09-21 Astute Medical Inc Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
CA2784889C (en) * 2009-12-20 2018-06-19 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Also Published As

Publication number Publication date
MX2013003204A (es) 2013-06-05
WO2012040592A1 (en) 2012-03-29
BR112013006631A2 (pt) 2017-10-24
JP2013541005A (ja) 2013-11-07
AU2011305197A1 (en) 2013-05-02
US20130252264A1 (en) 2013-09-26
KR20140051099A (ko) 2014-04-30
CN106248921A8 (zh) 2017-07-21
AU2011305197B2 (en) 2015-06-11
EP2619231B1 (en) 2016-12-21
CN103189394B (zh) 2016-08-17
EA201390294A1 (ru) 2013-09-30
ES2619617T3 (es) 2017-06-26
NZ609126A (en) 2015-05-29
CA2813011A1 (en) 2012-03-29
EP2619231A1 (en) 2013-07-31
EP2619231A4 (en) 2014-04-30
CN103189394A (zh) 2013-07-03
CN106248921A (zh) 2016-12-21

Similar Documents

Publication Publication Date Title
EP2539712A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2767833A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX336280B (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
MX341191B (es) Metodos y composiciones para diagnostico y prognosis de lesion renal y falla renal.
EP2813848A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3734280A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ625423A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
TR201904386T4 (tr) Nükleotidleri içeren nükleozomların saptanmasına yönelik yöntem.
MX2019008260A (es) Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c.
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2011008323A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
NZ608384A (en) Biomarkers of renal injury
WO2011015944A3 (en) Use of free dna as an early predictor of severity in acute pancreatitis
MX2014000283A (es) Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal.
MX2017005126A (es) Metodos y composiciones para el diagnostico y pronostico de lesion renal e insuficiencia renal.
MX2012003168A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal.
MX2014002030A (es) Biomarcadores de carcinoma de celulas renales y usos de los mismos.
MX2012005218A (es) Metodos y composiciones para el diagnostico y pronostico de daño renal y falla renal.
WO2012094658A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2013066879A3 (en) SOLUBLE UROKINASE RECEPTOR (suPAR) IN DIABETIC KIDNEY DISEASE
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012089753A3 (en) Complex sets of mirnas as non-invasive biomarkers for glioblastoma
WO2011084548A3 (en) Methods and compositions for detecting recessive familial fsgs and uses thereof
IN2014DN08312A (es)

Legal Events

Date Code Title Description
FG Grant or registration